AHS Cancer Control Alberta: all 187 studies

Page 1 of 2. Open to participants first (31), then studies with results posted, then the rest; newest registration first within each.

• Radiation Treatment of the Prostate That is Specially Adjusted for Each PersonRecruitingNCT07578519Phase 2
• Stereotactic Body Radiation Therapy (SBRT) and Immunotherapy for Oligometastatic Esophageal CancerNot yet recruitingNCT07330583Phase 2
• PSMA-PET Directed Radiation Therapy for High-Risk Prostate CancerNot yet recruitingNCT07291557Phase 2
• This Study is Comparing Morning vs Random Scheduling of Standard of Care Pembrolizumab Checkpoint Inhibitor Immunotherapy Infusions in Patients With Metastatic Non-small Cell Lung CancerNot yet recruitingNCT06882174Phase 2
• Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor PneumonitisRecruitingNCT06860542Phase 2
• COACH - Comparing Two Different Methods to Suppress Thyrotropin in Patients With Advanced Thyroid CancerNot yet recruitingNCT06790589Phase 2
• Vedolizumab for the Prevention of ICI Related Diarrhea or Colitis in Patients With CancerRecruitingNCT06337695Phase 2/3
• PET/MRI in Rectal CancerNot yet recruitingNCT06057831Phase 2
• SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver MetastasesRecruitingNCT05775146Phase 2
• Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo)RecruitingNCT05663775Phase 2
• Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)RecruitingNCT05451043Phase 2
• Pilot Trial for Treatment of Recurrent GlioblastomaRecruitingNCT05432518Early Phase 1
• Loratadine for the Prevention of G-CSF-related Bone PainRecruitingNCT05421416Phase 2
• Northern Alberta Linac-MR Image-Guided Radiotherapy (Northern LIGHTs-2)RecruitingNCT05413473Phase 1/2
• Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)RecruitingNCT05407987Phase 3
• Nutritional Supplementation in Head and Neck CancersRecruitingNCT05379712Phase 2
• A Study Involving Neoadjuvant Chemoradiotherapy with Hypofractionated Radiotherapy in Patients with Esophageal and Gastroesophageal Junction AdenocarcinomaRecruitingNCT05370144Not applicable
• High Heated Humidity in Stem Cell TransplantRecruitingNCT05358262Phase 2
• Steroid Sparing in Immune Related Hepatitis (irH)RecruitingNCT05345847Not applicable
• Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC)Not yet recruitingNCT05128734Phase 2
• Inguinal Node Sparing Radiotherapy For Patients With Early Stage Anal CancerRecruitingNCT05040815Phase 2
• Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung CancerRecruitingNCT04952480Phase 2
• Chemoradiotherapy Versus Chemotherapy for Elderly and Frail GBM PatientsRecruitingNCT04765514Phase 2
• Tamoxifen Versus Etoposide After First Recurrence in GBM PatientsRecruitingNCT04765098Phase 2
• MR Imaging Study Using the Northern Alberta Linac-MR (Northern LIGHTs - 1)RecruitingNCT04358913Not applicable
• Immune-Mediated Pathophysiology And Clinical Triage ProgramRecruitingNCT04354649Phase 2
• A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home EnvironmentRecruitingNCT04268199Phase 2
• Trial of Combined Radiotherapy and Vertebroplasty for Patients With Painful Metastatic Spinal LesionsRecruitingNCT04242589Phase 2
• p16+ Oropharyngeal Cancer Radiation Optimization Trial Reducing Elective Treatment Volumes (PROTEcT)RecruitingNCT04104945Not applicable
• Chemoradiotherapy for Advanced Esophageal CancerRecruitingNCT02297217Phase 2
• A Study of Genetic Based Chemotherapy Dosing for Breast Cancer PatientsRecruitingNCT01740271Phase 2
• Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP)CompletedNCT03391973Phase 2Results posted
• GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part SarcomaCompletedNCT06827886Early Phase 1
• GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma (CLIC-YYC-GPNMB-02)Active, not recruitingNCT06789081Early Phase 1
• Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1)TerminatedNCT06001125Phase 2
• A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate CancerTerminatedNCT05712174Phase 2
• PSMA-PET/CT RegistryTerminatedNCT05709535
• BIOmarker-guided Study to Evaluate the Efficacy and Safety of cemipLimab for advancEd Cutaneous T-cell LymphomaWithdrawnNCT05538988Phase 1/2
• Participating in Tai Chi to Reduce Anxiety and Keep up Physical FunctionActive, not recruitingNCT05452824Not applicable
• Prognostic Indicators for Radiation-induced Breast FibrosisTerminatedNCT05031065
• Exercise and Compression for LymphedemaCompletedNCT05022823Not applicable
• A Research Study to Collect Patient Reported Outcomes Using Electronic SurveysTerminatedNCT04990895Not applicable
• iTTo for Treatment Naive Advanced Gastric or Gastroesophageal Junction (GEJ) AdenocarcinomaCompletedNCT04808791Phase 2
• mHealth Physical Activity Intervention for Young Cancer SurvivorsActive, not recruitingNCT04765241Not applicable
• Study of Niacin in GlioblastomaActive, not recruitingNCT04677049Phase 1/2
• Pre- Versus Post-operative SRS for Resectable Brain MetastasesTerminatedNCT04474925Phase 3
• Accelerated Checkpoint Therapy for Any Steroid Dependent Patient With Brain MetastasesTerminatedNCT04461418Phase 2
• Virtual Overdose ResponseWithdrawnNCT04391192Not applicable
• Pressure injuRy preventiOn by inTermittent EleCtrical sTimulationTerminatedNCT04328246Phase 3
• A Nutritional Supplement to Support People With Non-small Cell Lung CancerActive, not recruitingNCT04175769Not applicable
• A Study of Trifluridine/Tipiracil in Triple Negative Metastatic Breast CancerWithdrawnNCT04149444Phase 2
• Nivolumab Plus Pemetrexed for Head and Neck Squamous Cell CarcinomaCompletedNCT04107103Phase 2
• Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant SettingActive, not recruitingNCT03831178Phase 2
• The UNSCARRed Study: UNresctable Squamous Cell Carcinoma Treated With Avelumab and Radical RadiotherapyTerminatedNCT03737721Phase 2
• Unilateral Neck Radiotherapy in Head and Neck CancerTerminatedNCT03622164Not applicable
• The Breast Cancer & Physical Activity Level (BC-PAL) Pilot StudyCompletedNCT03564899Not applicable
• A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.TerminatedNCT03469011Phase 1
• HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD ProphylaxisTerminatedNCT03456817Phase 2
• Avelumab With Valproic Acid in Virus-associated CancerCompletedNCT03357757Phase 2
• A Study to See Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver SafelyStatus unknownNCT03175146Not applicable
• A Study to Evaluate a New Way to Identify/Diagnose Tumours With Somatostatin Receptors Using [68]Ga-HA-DOTATATE and to Ensure it is Safe to UseTerminatedNCT03145857Phase 1/2
• Nutraceuticals Versus Usual Care in the Prevention or Reduction of CIPN in Patients Treated With Docetaxel as Neoadjuvant/Adjuvant Breast Cancer TherapyTerminatedNCT02795572Phase 2
• RATIO: Rational Approach To Immuno-OncologyCompletedNCT02700971Not applicable
• APBI: 27Gy in 5 Fractions for Early Breast CancerStatus unknownNCT02681107Not applicable
• Multi-Parametric Brain Cancer MRICompletedNCT02649699Not applicable
• A Study to See the Effects That a New Combination of the Three Drugs, Nab-paclitaxel, Gemcitabine, and Cisplatin Has on Biliary Tract CancerActive, not recruitingNCT02632305Phase 2
• Rosuvastatin in the Treatment of Rectal CancerCompletedNCT02569645Phase 2
• Effects of LBM and PPIs on Pharmacokinetics and Safety of Regorafenib (BAY 73-4506) in Cancer PatientsWithdrawnNCT02439723Phase 1
• Study of Muscle Energy Metabolism in RCC Patients Treated With SunitinibWithdrawnNCT02428335
• GEMHDM2014 : Gem-HDM HDT and ASCT for Relapsed/ Refractory LymphomaTerminatedNCT02295722Phase 1/2
• A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast CancersActive, not recruitingNCT02238808Phase 2
• Trial of Hypofractionated Radiation Therapy for GlioblastomaCompletedNCT02206230Phase 2
• Studying if Adding Night Compression to Standard Care Will Have Improved Control of Lymphedema in Breast Cancer SubjectsCompletedNCT02187289Not applicable
• A Study to Evaluate the Good and Bad Effects of BIBF1120 in Small Cell Lung Cancer Patients Who Have Previously Benefited From First-line Platinum-based ChemotherapyWithdrawnNCT02152059Phase 2
• A Phase I Dose Escalation Study of Erlotinib in Combination With TheophyllineTerminatedNCT02080078Phase 1
• Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the HeartStatus unknownNCT02052102Phase 2
• A Study for Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate GlandCompletedNCT02004418Phase 1/2
• Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the ProstateTerminatedNCT01996696Phase 2
• Comparison Study of Family Practice Interventions for Depression in AdultsCompletedNCT01975207Not applicable
• A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine TumoursSuspendedNCT01876771Phase 2
• A Phase III Study of Re-Irradiation in Recurrent GlioblastomaWithdrawnNCT01830101Phase 3
• Review of Medical Records of Patients Who Have Been Treated With Lutetium at the Cross Cancer Institute Between January 2010 and April 30, 2014Active, not recruitingNCT01763554
• An Imaging Study in Patients With Thyroid Cancer or Head and Neck Cancer With Pertechnetate Made in a Cyclotron (C-PERT)WithdrawnNCT01747512Phase 2
• A Study Comparing Chemotherapy Dosing Based on Either Standard Body Surface Area or Lean Body Mass in Patients With Advanced Lung CancerStatus unknownNCT01624051Phase 2
• A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas CancerStatus unknownNCT01586611Phase 3
• An Initial Feasibility Study to Integrate MRI Based Brachytherapy and CT/MR Fused INRT in Treatment of Advance Cervical CancerWithdrawnNCT01514955Phase 1
• Study of ABT-888 in Combination With Bortezomib and Dexamethasone in Patients With Relapsed Refractory MyelomaCompletedNCT01495351Phase 1
• Conventional Versus Hypofractionated Radiation in High Risk Prostate PatientsTerminatedNCT01488968Not applicable
• To Compare Safety and the General Imaging Pattern of Cyclotron Produced Technetium vs. Generator Produced Technetium in Patients With Thyroid CancerCompletedNCT01437254Phase 1
• A Study to Measure Needle Bending and Changes in Prostate Shape During a Prostate Seed ImplantStatus unknownNCT01437085
• Breast Cancer and Exercise Trial in AlbertaCompletedNCT01435005Not applicable
• Correlation Between MRS (Magnetic Resonance Spectroscopy) and Tumor Response to Radiation Therapy in Breast CancerCompletedNCT01428739Not applicable
• Pilot Project of Adaptive Thoracic Radiotherapy for Small Cell Lung CancerStatus unknownNCT01426841Phase 1
• Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas CancerStatus unknownNCT01411072Not applicable
• TORI 104 Pre-Surgical DasatinibWithdrawnNCT01410708Phase 2
• Seed Movement in Prostate Brachytherapy Implants: Clinical Measurement and Dosimetric ConsequencesStatus unknownNCT01355185
• Oxaliplatin Pharmacokinetics With and Without Ca2+/MG2+ Infusion in Colorectal Cancer PatientsStatus unknownNCT01157052Phase 1
• A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of OxaliplatinWithdrawnNCT01157039Phase 2
• A Feasibility Study to Compare the Benefits of Endoscopic Tumor Clip Placement and 3T-MRI Simulation for Accurate Target Volume Definition for Rectal Cancer Patients Undergoing Pre-operative ChemoradiationCompletedNCT01133340Not applicable
• First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer.CompletedNCT01129310Phase 2

← AHS Cancer Control Alberta overview and focus areas